Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,342Revenue $M259Net Margin (%)-8.0Altman Z-Score91.5
Enterprise Value $M6,263EPS $-0.3Operating Margin %-7.7Piotroski F-Score7
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-8.0Higher ROA y-yY
Price/Book42.210-y EBITDA Growth Rate %-23.7Quick Ratio3.5Cash flow > EarningsY
Price/Sales21.35-y EBITDA Growth Rate %-27.5Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow661y-y EBITDA Growth Rate %--ROA % (ttm)-14.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-19.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M79.3ROIC % (ttm)-42.6Gross Margin Increase y-yY

Gurus Latest Trades with DXCM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DXCMJoel Greenblatt 2015-03-31 Sold Out -0.0044%$54.21 - $64.42
($60.43)
$ 79.3631%Sold Out0
DXCMRon Baron 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 79.3631%Reduce 0.17%1,338,407
DXCMMario Gabelli 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 79.3631%Reduce 1.55%50,800
DXCMMario Gabelli 2014-12-31 Reduce$40.37 - $58.3
($49.09)
$ 79.3662%Reduce 21.82%51,600
DXCMJoel Greenblatt 2014-12-31 Buy $40.37 - $58.3
($49.16)
$ 79.3661%New holding9,915
DXCMJoel Greenblatt 2014-09-30 Sold Out $35.35 - $45.89
($41.06)
$ 79.3693%Sold Out0
DXCMJoel Greenblatt 2014-06-30 Buy $29.68 - $41.95
($35.37)
$ 79.36124%New holding8,033
DXCMGeorge Soros 2013-09-30 Sold Out -0.02%$21.78 - $29.19
($25.33)
$ 79.36213%Sold Out0
DXCMGeorge Soros 2013-03-31 Buy 0.02%$13.59 - $17.05
($15.22)
$ 79.36421%New holding100,000
DXCMRon Baron 2012-12-31 Buy 0.11%$12.3 - $14.95
($13.39)
$ 79.36493%New holding1,250,000
DXCMGeorge Soros 2011-09-30 Sold Out -0.0025%$10.3 - $15.66
($12.98)
$ 79.36511%Sold Out0
DXCMGeorge Soros 2011-06-30 Buy $13.05 - $16.72
($15.24)
$ 79.36421%New holding12,500
DXCMMario Gabelli 2011-03-31 Reduce-0.01%$13.3 - $15.79
($14.39)
$ 79.36451%Reduce 55.46%77,500
DXCMGeorge Soros 2011-03-31 Sold Out $13.3 - $15.79
($14.39)
$ 79.36451%Sold Out0
DXCMGeorge Soros 2010-09-30 Reduce$10.76 - $14.06
($12.31)
$ 79.36545%Reduce 43.37%14,100
DXCMGeorge Soros 2010-06-30 Buy 0.01%$9.22 - $11.65
($10.48)
$ 79.36657%New holding24,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DXCM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DXCM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MOY JEFFREYSVP, Operations 2015-06-23Sell5,154$77.542.35view
Balo Andrew KEVP, Clinical, Regulatory 2015-06-23Sell5,573$77.542.35view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2015-06-23Sell14,000$77.532.36view
ROPER JESSSVP, CFO 2015-06-18Sell7,000$77.12.93view
SKYLER JAY SDirector 2015-06-15Sell20,000$70.6712.3view
GREGG TERRANCE HExecutive Chairman 2015-06-15Sell15,000$70.9411.87view
MOY JEFFREYSVP, Operations 2015-06-11Sell9,869$738.71view
MOY JEFFREYSVP, Operations 2015-06-09Sell5,000$70.6312.36view
VALDES JORGE ACTO 2015-06-09Sell19,680$71.3211.27view
Balo Andrew KEVP, Clinical, Regulatory 2015-06-09Sell7,500$70.6212.38view

Quarterly/Annual Reports about DXCM:

News about DXCM:

Articles On GuruFocus.com
Dexcom’s Smart Glucose Monitoring System Receives FDA Approval Jan 27 2015 
Top Insider Sells Highlight: Dexcom Inc. Aug 22 2014 
DexCom Reports $1 Million Insider Buy Mar 12 2013 
DexCom Inc. Reports Operating Results (10-Q) Aug 03 2010 
DexCom Inc. Reports Operating Results (10-Q) May 05 2010 
DexCom Inc. Reports Operating Results (10-Q) Nov 04 2009 
DexCom Inc. Reports Operating Results (10-Q) Aug 03 2009 
DexCom Inc. Reports Second Quarter 2009 Financial Results Aug 03 2009 
DexCom Inc. (DXCM) CEO Terrance H Gregg buys 20,000 Shares May 14 2009 
DexCom Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
Dexcom and Nick Jonas Raise Their Voices for Diabetes Awareness Jun 11 2015
Dexcom and Nick Jonas Raise Their Voices for Diabetes Awareness Jun 11 2015
DexCom's (DXCM) Follow CGM App Now on Android Devices - Analyst Blog Jun 03 2015
DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or... Jun 02 2015
Dexcom® Announces Follow App is Now Available for Android Devices Jun 02 2015
Dexcom® Announces Follow App is Now Available for Android Devices Jun 02 2015
DexCom Announces Upcoming Conference Presentations May 29 2015
DexCom Announces Upcoming Conference Presentations May 29 2015
DexCom Hits 52-Week High, Robust Pipeline Key Catalyst - Analyst Blog May 28 2015
4 Biotech Stocks Could Have Big Upside Before Russell Index Changes May 12 2015
10-Q for DexCom, Inc. May 01 2015
DexCom (DXCM) Q1 Loss Wider Than Expected; Shares Fall - Analyst Blog Apr 30 2015
After-hours buzz: Yelp, Glu Mobile, Baidu & more Apr 29 2015
DexCom reports 1Q loss Apr 29 2015
DexCom reports 1Q loss Apr 29 2015
DexCom, Inc. Reports First Quarter 2015 Financial Results Apr 29 2015
DexCom Inc Earnings Call scheduled for 4:30 pm ET today Apr 29 2015
DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Apr 29 2015
DexCom, Inc. Reports First Quarter 2015 Financial Results Apr 29 2015
Q1 2015 DexCom Inc Earnings Release - After Market Close Apr 29 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK